European stocks that trade on US exchanges as American depositary receipts (ADRs) started the week on a slightly softer note, with the S&P Europe Select ADR Index slipping 0.14% late Monday morning. The modest decline masked some notable individual moves, as Spain's Banco Santander climbed 3.2% and UK-based Bicycle Therapeutics surged 17%.
What are ADRs and why do they matter?
ADRs are essentially foreign shares that are packaged and sold in dollars on US exchanges. They allow everyday American investors to buy stakes in overseas companies without dealing with foreign currencies or international brokerage accounts. For example, when you buy an ADR for a European bank, you own a claim on that bank's shares, but the trading happens in US dollars on a US exchange.
Because ADRs trade in dollars, their daily price moves are influenced by three forces: the performance of the underlying stock in its home market, the exchange rate between the dollar and the home currency, and the dynamics of US trading hours, which often have thinner liquidity than the home market. This blend explains why the overall index barely moved even as some stocks swung sharply.
Why the index was flat while some stocks jumped
The S&P Europe Select ADR Index tracks a broad basket of European companies, so a single stock's surge or slump has limited impact on the overall index. Monday's 0.14% dip suggests that most European ADRs were slightly lower, offsetting the gains from Santander and Bicycle Therapeutics.
Banco Santander, one of Europe's largest banks, rose 3.2%—a notable move for a financial heavyweight. The gain could reflect positive sentiment toward the bank's earnings outlook or broader strength in European banking stocks. Bicycle Therapeutics, a biotech company, jumped 17%, likely driven by company-specific news such as a clinical trial update or partnership announcement. Such moves are common in the biotech sector, where a single data point can swing valuations dramatically.
What this means for investors
For everyday investors, the takeaway is that ADRs offer a convenient way to diversify internationally, but they come with extra layers of risk. Currency fluctuations can either boost or erode returns. For instance, if the euro weakens against the dollar, even a rising European stock could translate into a flat or lower ADR price. Conversely, a stronger euro can amplify gains.
Liquidity is another factor. Because ADRs trade in US hours, they may have fewer buyers and sellers than the underlying shares in their home markets. This can lead to wider bid-ask spreads and more volatile price swings, especially for smaller companies like Bicycle Therapeutics.
Investors should also remember that a single day's move in an index like this is rarely a signal of a broader trend. The 0.14% decline is essentially flat, and the index's performance over the week will depend on a mix of corporate news, economic data, and currency movements. For context, European ADRs have recently been sensitive to currency swings, and the dollar's strength has been a recurring theme. Meanwhile, the dollar has held firm as European bond stress deepened, which could continue to pressure ADR returns.
Looking ahead
Investors will be watching for any catalysts that could move European markets this week, including economic data releases, central bank commentary, and corporate earnings. The Federal Reserve's meeting minutes are due later this week and could offer clues about the path of US interest rates, which in turn affects the dollar and, by extension, ADR valuations.
For those holding European ADRs, the key is to stay focused on the long-term fundamentals of the companies they own, rather than reacting to daily index moves. As always, diversification across regions and sectors can help manage the added risks of international investing.
